This topic contains a solution. Click here to go to the answer

Author Question: The greatest limitation to patient use of a dry powder inhaler (DPI) is a. patient preference. ... (Read 42 times)

frankwu

  • Hero Member
  • *****
  • Posts: 549
The greatest limitation to patient use of a dry powder inhaler (DPI) is
 
  a. patient preference.
  b. patient coordination.
  c. patient ability to provide an inspiratory flow rate of 30 to 90 L/min.
  d. cost.

Question 2

The physician has granted your request to change a patient from a small volume nebulizer (SVN) to a metered dose inhaler (MDI) for administration of albuterol. The dose via SVN was 2.5 mg of drug.
 
  What is the equivalent dose via MDI to administer to your patient?
  a. 1 puff
  b. 2 puffs
  c. 3 puffs
  d. 4 puffs



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

popopong

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

ANS: C

Answer to Question 2

ANS: B




popopong

  • Sr. Member
  • ****
  • Posts: 307

 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library